Ectopic preg - Large Biopsy 3-6 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histopathology of ectopic pregnancy tissue.

₹666₹951

30% OFF

Ectopic Pregnancy - Large Biopsy 3-6 cm: Comprehensive Medical Test Guide

Why is it done?
- Test Description: Histopathological examination of tissue biopsies (3-6 cm in size) obtained from suspected ectopic pregnancy sites, typically from fallopian tubes, ovaries, or peritoneal tissue.
- Primary Indications: Confirmation of ectopic pregnancy diagnosis when ultrasound findings are inconclusive; determination of gestational age and viability; identification of trophoblastic tissue; assessment for concurrent intrauterine pregnancy; evaluation of retained products of conception following ectopic pregnancy treatment.
- Timing and Circumstances: Performed following surgical removal of ectopic pregnancy tissue (laparoscopy or laparotomy); when conservative management or medical therapy has been attempted and tissue has been obtained; in cases of diagnostic uncertainty regarding pregnancy location; as part of post-operative evaluation to confirm complete removal of gestational tissue.
Normal Range
- Normal Findings: Presence of chorionic villi and/or trophoblastic tissue confirming pregnancy; appropriate gestational age-specific changes in trophoblast; evidence of implantation in fallopian tube wall, ovarian tissue, or peritoneal implantation site; absence of intrauterine pregnancy components.
- Reference Interpretation: Positive: Histological confirmation of trophoblastic tissue in ectopic location (abnormal but expected finding confirming diagnosis); Negative: Absence of pregnancy-related tissue, raising questions about diagnosis or incomplete specimen collection.
- Units of Measurement: Qualitative histopathological assessment (presence/absence of specific tissue types); tissue size in centimeters (3-6 cm); microscopic description of cellular architecture and gestational age indicators.
- Interpretation Classification: Normal = Appropriate pregnancy tissue in abnormal location; Abnormal = No pregnancy tissue found, tissue inconsistent with pregnancy, or evidence of malignancy; Inconclusive = Inadequate sampling or tissue too autolytic for clear assessment.
Interpretation
- Positive for Chorionic Villi/Trophoblastic Tissue: Confirms diagnosis of ectopic pregnancy; indicates pregnancy successfully implanted and developed outside uterine cavity; gestational age assessment aids in determining how long pregnancy has been developing; villi complexity suggests viability at time of removal; presence in fallopian tube most common; ovarian or peritoneal sites less common but possible.
- Negative for Pregnancy Tissue: May indicate false diagnosis of ectopic pregnancy; suggests tissue obtained may not have included gestational material; possible miscarriage with incomplete removal; requires clinical correlation with imaging and laboratory findings; may necessitate additional imaging to verify diagnosis.
- Early vs. Advanced Gestational Changes: Early gestation (6-8 weeks): Simple villi with single layer of trophoblast; intermediate gestation (9-12 weeks): More complex villi with increased vascularity; advanced gestation (>12 weeks): Large villi with developed placental architecture; assists in clinical dating and determining rupture risk.
- Factors Affecting Results: Specimen size and adequacy; tissue autolysis and freezing artifacts; previous medical treatment (methotrexate effects); prior instrumentation affecting tissue integrity; location of biopsy site relative to gestational sac; patient's immune response to pregnancy tissue; contamination with maternal decidua.
- Clinical Significance Patterns: Confirms ectopic diagnosis and validates surgical approach; guides post-operative monitoring (hCG levels should decline); identifies whether all gestational tissue was removed; helps predict risk of future ectopic pregnancies; provides documentation for clinical records and pathology reporting; assists in counseling regarding reproductive prognosis.
Associated Organs
- Primary Organ Systems Involved: Fallopian tubes (most common ectopic site, 95% of cases); ovaries (ovarian pregnancy, 3-5%); peritoneal cavity (peritoneal pregnancy, rare); abdominal organs (liver, spleen in rare abdominal pregnancies); uterus (to exclude concurrent intrauterine pregnancy); cervix and vagina (cervical pregnancy, rare).
- Associated Medical Conditions: Pelvic inflammatory disease (tubal scarring); endometriosis; intrauterine adhesions (Asherman's syndrome); tubal surgery or ligation; previous ectopic pregnancy; sexually transmitted infections; intrauterine device use; embryo implantation failure with pathologic migration; immunological rejection of pregnancy.
- Diseases Diagnosed or Monitored: Ectopic pregnancy (definitive diagnosis); heterotopic pregnancy (coexistence of intrauterine and ectopic); persistent ectopic pregnancy (after attempted conservative management); gestational trophoblastic disease (molar pregnancy presenting as ectopic); tubal pathology assessment; evaluation of chronic pelvic pain etiology.
- Potential Complications and Risks: Rupture of affected organ (fallopian tube, ovarian vessel) with massive hemorrhage; intra-abdominal bleeding requiring emergency intervention; sepsis from infected pregnancy tissue; shock from hypovolemia; loss of reproductive organ (tubal loss reduces fertility); psychological trauma from pregnancy loss; future ectopic pregnancy risk (25-30% increased); reduced fertility and increased miscarriage risk in subsequent pregnancies.
Follow-up Tests
- Immediate Post-Operative Testing: Serum beta-hCG (human chorionic gonadotropin) at 24-48 hours post-surgery to confirm decline; should decrease by at least 50% every 3-7 days after removal of ectopic tissue; levels plateauing or increasing suggest retained gestational material.
- Ongoing Monitoring: Serial hCG measurements weekly until negative (typically 2-6 weeks post-operatively); transvaginal ultrasound if hCG levels plateau or increase to assess for retained products; repeat pelvic examination at post-operative visit; assessment for signs of infection or complications.
- Further Investigations if Results Inconclusive: High-resolution transvaginal ultrasound to confirm tissue removal and evaluate residual findings; CT imaging if recurrent or atypical ectopic pregnancy suspected; diagnostic laparoscopy for visualization and assessment of remaining tissue; immunohistochemical staining (if performed on initial biopsy) for cytokeratin to confirm trophoblastic origin.
- Complementary Diagnostic Tests: Hemoglobin/hematocrit to assess for anemia from blood loss; coagulation studies if significant hemorrhage occurred; pelvic ultrasound to evaluate for free fluid, abscess formation, or structural damage; hysterosalpingogram at 2-3 months post-operatively to assess tubal patency if future fertility desired.
- Long-term Follow-up Frequency: Immediate post-op (24-48 hours): hCG and vital signs; weekly thereafter: hCG until undetectable; at 2-4 weeks: surgical site evaluation and symptom assessment; at 2-3 months: counseling regarding future pregnancy planning and repeat ectopic risk; ongoing: annual gynecologic evaluation if tubal preservation achieved.
Fasting Required?
- Fasting Requirement: No - Fasting is not required for this histopathological tissue examination. The biopsy is obtained surgically during laparoscopy or laparotomy, not from blood draw.
- Pre-operative Preparation: NPO (nothing by mouth) status required as for any surgical procedure: typically 6-8 hours before surgery; clear liquids may be permitted up to 2 hours before procedure per surgeon's protocol.
- Medications to Avoid: Anticoagulants (warfarin, apixaban) - typically discontinued 3-5 days pre-operatively; antiplatelet agents (aspirin) - may be continued or discontinued per surgeon; NSAIDs - typically avoided 1 week before surgery; herbal supplements with anticoagulant properties (ginseng, ginkgo); discuss all medications with surgeon at pre-operative visit.
- Other Patient Preparation Requirements: Complete pre-operative laboratory work (CBC, type and cross for blood availability); electrocardiogram if indicated by age or medical history; chest X-ray if clinically indicated; anesthesia consultation and clearance; informed consent discussing surgical approach, risks, and biopsy procedures; arrange for responsible adult to provide transportation home; plan for post-operative recovery time (typically 1-2 weeks off work); prepare abdomen per surgical protocol (may include showering with antimicrobial soap); remove nail polish, jewelry, and dentures on day of surgery; void before pre-medication administration.

How our test process works!